The paradox of spironolactone: A heart failure treatment with potentially harmful effects
Madam, Heart failure (HF) is a multifaceted clinical syndrome arising from a functional or structural cardiac condition that hampers the adequate filling or expulsion of blood into the systemic circulation. It is estimated that heart failure affects around 26 million people globally and significa...
Main Authors: | Muhammad Roshan, Muhammad Ahmad Nadeem, Sahar Imran Khalfay |
---|---|
Format: | Article |
Language: | English |
Published: |
Pakistan Medical Association
2024-01-01
|
Series: | Journal of the Pakistan Medical Association |
Subjects: | |
Online Access: | http://ojs.jpma.org.pk/index.php/public_html/article/view/10270 |
Similar Items
-
The paradox of spironolactone: A heart failure treatment with potentially harmful effects
by: Muhammad Roshan, et al.
Published: (2024-01-01) -
Hospital Variation of Spironolactone Use in Patients Hospitalized for Heart Failure in China—The China PEACE Retrospective Heart Failure Study
by: Yuan Yu, et al.
Published: (2022-10-01) -
Retrospective analysis of adverse events with spironolactone in females reported to the United States Food and Drug Administration
by: Yu Wang, BA, et al.
Published: (2020-09-01) -
Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study
by: Hui‐min Zhou, et al.
Published: (2023-02-01) -
Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
by: Moritz Schnelle, et al.
Published: (2021-10-01)